Font Size: a A A
Keyword [NK/T-cell lymphoma]
Result: 21 - 40 | Page: 2 of 9
21. The Clinical Treament And Prognostic Factors Of 60 Nasal NK/T Cell Lymphoma Patients
22. A Case Of Natural Killer Cell Lymphoma With Elevated Adenosine Deaminase Level In Pleural Effusion
23. NK/T-cell Lymphoma: Report Of 2 Cases And Literature Review
24. Analysis Of Clinical Characteristics And Prognostic Factors Of 50 Cases Nasal NK/T-Cell Lymphoma
25. The Drug-sensitivity Of SNK-6 Cell To Platinum In Vitro And Mdr-1 Expression
26. A Preliminary Study On Bmi-1 Expression In Extranodal Nk/t-cell Lymphoma And Its Clinical Significance
27. Expression Of USP22in NK/T Cell Lymphoma And Its Significance
28. Prognostic Features And Treatment Of Locoregionally Recurrent Extranodal Nasal-type NK/T-Cell Lymphoma
29. Expression Of PTEN In NK/T Cell Lymphoma And Its Significance
30. The Analysis Of The Expression Of Asparagine Synthetase And The Efficacy Of Asparaginase-based Chemotherapy Among ENKTL Patients
31. Clinical Features And Treatment Outcome Of Tonsil Extranodal NK/T-cell Lymphoma, Nasal-type:A Multi-Center Study
32. Research On The Treatment Modality, Radiotherapy Planning And Prognostic Factors Of Early Stage Extranodal Natural Killer/T-cell Lymphoma
33. The Expression And Significance Of MiRNA-155 In NK/T Lymphoma Cells
34. Outcome Of L-Asp-based Chemotherapy In Nasal NK/T-cell Lymphoma And Detection Of Anti-lymphoma Activities Of Terpenoids From Four Plants
35. The Study Of Hedgehog And STAT3 Signaling Pathways In T-cell Lymphoma
36. Prognostic Nomogram And Risk-adapted Therapy For Extranodal NK/T-Cell Lymphoma, Nasal-Type
37. Establishment Of A Gemcitabine-resistant Cell Line Of Human NK/T Lymphoma And Detection Of Differential Genes Expression
38. Analysis Of Ki-67Expression As A Predictive Factor Of Prognosis In Patients With NK/T-cell Lymphoma
39. Analysis Of Prognostic Factors Of108Cases With Extranodal NK/T Cell Lymphoma
40. A Study On The Proliferative Activity Of Nasal NK/T Cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to